GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Human Xtensions Ltd (XTAE:HUMX) » Definitions » EV-to-FCF

Human Xtensions (XTAE:HUMX) EV-to-FCF : 0.08 (As of Dec. 12, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Human Xtensions EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Human Xtensions's Enterprise Value is ₪-2.89 Mil. Human Xtensions's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was ₪-34.50 Mil. Therefore, Human Xtensions's EV-to-FCF for today is 0.08.

The historical rank and industry rank for Human Xtensions's EV-to-FCF or its related term are showing as below:

XTAE:HUMX' s EV-to-FCF Range Over the Past 10 Years
Min: -57.46   Med: 0.09   Max: 1.13
Current: 0.07

During the past 6 years, the highest EV-to-FCF of Human Xtensions was 1.13. The lowest was -57.46. And the median was 0.09.

XTAE:HUMX's EV-to-FCF is ranked better than
98.12% of 373 companies
in the Medical Devices & Instruments industry
Industry Median: 28.7 vs XTAE:HUMX: 0.07

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-12), Human Xtensions's stock price is ₪0.315. Human Xtensions's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was ₪-1.370. Therefore, Human Xtensions's PE Ratio (TTM) for today is At Loss.


Human Xtensions EV-to-FCF Historical Data

The historical data trend for Human Xtensions's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Human Xtensions EV-to-FCF Chart

Human Xtensions Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial - -20.21 -0.69 0.90 -0.33

Human Xtensions Quarterly Data
Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 -0.53 -0.05 -0.33 0.13

Competitive Comparison of Human Xtensions's EV-to-FCF

For the Medical Devices subindustry, Human Xtensions's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Human Xtensions's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Human Xtensions's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Human Xtensions's EV-to-FCF falls into.



Human Xtensions EV-to-FCF Calculation

Human Xtensions's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=-2.893/-34.496
=0.08

Human Xtensions's current Enterprise Value is ₪-2.89 Mil.
Human Xtensions's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪-34.50 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Human Xtensions  (XTAE:HUMX) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Human Xtensions's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.315/-1.370
=At Loss

Human Xtensions's share price for today is ₪0.315.
Human Xtensions's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪-1.370.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Human Xtensions EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Human Xtensions's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Human Xtensions Business Description

Traded in Other Exchanges
N/A
Address
Meir Ariel 4, Tel Aviv, ISR
Human Xtensions Ltd is engaged in the business of developing handheld digital solutions for minimally invasive surgery. It develops unmediated surgical systems that combine the capacity of robotics with the benefits of handheld tools and ergonomic bed mounts. The company's product, HandX, is designed as a light-weight, hand-held device that translates the surgeon's natural hand motions into complex movements inside the patient.

Human Xtensions Headlines

No Headlines